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Aim: The potential for transmission of hepatitis C virus (HCV) in prison settings is well established and directly
associated with sharing of injecting and tattooing equipment, as well as physical violence. This study is one of
the first to examine the circumstances surrounding the acquisition of HCV in the prison setting via inmates’
own accounts.
Method: This is a sub-study of a cohort of prison inmates in New South Wales, Australia. Cohort participants were
inmates who had reported ever injecting drugs and who had a negative HCV serological test within 12 months
prior to enrolment. Cohort participants were monitored every 3 to 6 months for HCV antibodies and viraemia and
via behavioural risk practices questionnaire. Participants with a documented HCV seroconversion were eligible to
participate in in-depth interviews with a research nurse known to them.
Results: Participants included six inmates (four men, two women) with documented within-prison HCV seroconversion.
Participants reported few changes to their injecting practices or circumstances that they attributed to HCV acquisition.
Participants believed that they were sharing syringes with others who were HCV negative and trusted that others would
have declared their HCV status if positive. Some participants described cleaning equipment with water, but not with
disinfectant. In a departure from usual routine, one participant suggested that he may have acquired HCV as a result of
using a syringe pre-loaded with drugs that was given to him in return for lending a syringe to another inmate.
Participants described regret at acquiring HCV and noted a number of pre- and post-release plans that this diagnosis
impacted upon.
Conclusions: Acquiring hepatitis C was not a neutral experience of participants but generated significant emotional
reactions for some. Decisions to share injecting equipment were influenced by participants’ assumptions of the HCV
status of their injecting partners. The social organisation of injecting, in trusted networks, is a challenge for HCV
prevention programs and requires additional research.
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Prisons are key settings for transmission of hepatitis C virus
(HCV) infection [1,2]. The illegality of injecting drug use
and subsequent high rates of incarceration of people who
inject drugs combined with the lack of access to sterile
injecting equipment places inmates at high risk of HCV
infection [3-5]. Cohort studies indicate significant rates of
HCV transmission in the custodial setting—particularly
among inmates who inject drugs [1,2,6]. In 2010, preva-
lence of hepatitis C was 22% among Australian prison* Correspondence: c.treloar@unsw.edu.au
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unless otherwise stated.entrants and 51% among those with a history of injecting
drug use [7].
Besides the high prevalence of HCV infection among
those coming into prison, injecting drug use has been
described as “normative” within prisons [8] with evi-
dence of inmates starting to share injecting equipment
within prison [9]. Furthermore, the lack of access to ster-
ile injecting equipment means that such equipment
becomes commodified and circulates for long periods as
broken equipment is harvested to build or repair others
[10,11]. In these situations, it appears impossible not to
share injecting equipment and, hence, produce elevated
risks of HCV transmission [12].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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situations in which HCV transmission occurs in prisons
to guide possible responses. This paper aims to address
this issue via a qualitative study of continuously incar-
cerated inmates with serologically documented incident
HCV infection. This paper sought to provide a contex-
tualised understanding of the individual, social and en-
vironmental circumstances in which HCV was acquired
by prison inmates. This project used qualitative research
methods to allow participants to fully discuss and explore
the practices and settings in which they perceived HCV
transmission to have occurred.
Method
Participants enrolled in the HITS-p cohort were eligible
for this qualitative study. The HITS-p cohort is a pro-
spective cohort of hepatitis C uninfected inmates who
report injecting drug use [1,13]. Appropriate human re-
search ethics committees (Corrective Services NSW,
Justice Health and Forensic Mental Health Network)
provided approval for the HITS-p cohort and for this
project. At enrolment to the cohort, all participants were
screened for HCV antibodies and HCV viraemia and
then monitored every 3 to 6 months via blood test and
interviewer-administered questionnaire to record behav-
ioural risk practices (particularly, injecting drug use, tat-
toos and fights). In our recent report of HCV incidence in
the cohort [1], the rate among continuously incarcerated
inmates was 10.3 per 100 person years. This analysis, how-
ever, did not provide an opportunity to explore the HCV
infection experience from the participant’s perspective.
Participants with a documented incident HCV infec-
tion (by antibody status) and who remained in prison
were eligible to be invited to participate in in-depth inter-
views with a research nurse (LM) known to them via the
cohort project. After written informed consent, qualitative
interviews were conducted within 1 to 6 months of diag-
nosis (that is, not immediately upon diagnosis but within a
period of time to facilitate recall of the events/settings
surrounding acquisition of hepatitis C). At the conclusion
of each interview, participants were offered written infor-
mation about hepatitis C, an opportunity to discuss any
further issues with the research nurse, and information
about access to the Prison Hep C Infoline. Participants
received AUD$10 for their participation in the interview
through the approved prison inmate banking system to
compensate for their time and effort in completing the
research interview.
The interview schedule included topics such as risk
(what risks are perceived by inmates; what risks can be
compromised or negotiated and what cannot); partici-
pant’s knowledge of hepatitis C, hepatitis C information
sources and perception of susceptibility to hepatitis C;
and injecting drug use, tattooing and violence (includingdetails of how, where, when, and with whom these activ-
ities occur; decisions/influences on safety and practice).
Participants were asked to discuss how they believe they
came to be infected with hepatitis C; had injecting practice
changed since diagnosis; and the importance of knowing
how HCV was acquired. Demographic information was
collected from all participants.
Interviews were audio-taped and transcribed verbatim.
Transcripts were checked for accuracy against record-
ings, de-identified and cleaned. The data was then read
closely, and a number of themes were identified as rele-
vant to the research questions. The research team then
collaborated on the construction of a “coding frame”—a
set of organising, interpretive themes to aid analysis.
The coding frame was then used to organise interview
data within NVivo 9. Analysis was informed by both a
deductive and inductive approach [14]. That is, each
case of incident HCV infection was reviewed to examine
the specific circumstances in which transmission may
have occurred as these data, from the participants’ per-
spective, have not been previously reported. To extend
the presentation of these cases, two specific risk factors
for HCV transmission (cleaning of equipment and
injecting networks) were examined using an inductive
thematic analysis approach. A final theme emerging
from the data, responses to HCV diagnosis, is also pre-
sented. Each aspect of the thematic analysis, that is, the in-
terpretations and meanings drawn from the interview
data, was critically examined and summarised (along with
supporting quotes). Quotes are presented by participant
number and with details of their gender, age, frequency of
injecting and HCV risk behaviours as reported on the
behavioural survey preceding HCV acquisition.
Results
Six participants (four males, two females) had docu-
mented incident HCV infection while continuously
imprisoned, were available to interview and were asymp-
tomatic. Two further participants also had documented
incident infection, but one participant attributed this to
injecting outside of prison and another terminated his
interview before questions about HCV acquisition could
be posed. Of the remaining six participants, two partici-
pants reported only injecting drug use as risk for HCV
exposure in their responses to the behavioural risk prac-
tice questionnaire in the period corresponding to their
HCV seroconversion; three participants reported inject-
ing drug use and other possible exposure to blood (via
tattooing, piercing, violence or haircuts) in the period
around their acquisition of HCV. Data on sex between
men was available for three of the four male participants
in the time period of HCV acquisition; none of these
male participants reported sex with men. One partici-
pant reported being on opiate substitution treatment
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were located in six different prisons at the time of the
interview. Participants ranged in age from 22 to 31 years.
Three participants identified as Anglo-Australian, two as
Indigenous Australians and one as Polynesian. Five partic-
ipants reported 10 years or less of formal schooling and
one participant reported technical studies post-schooling.
Participants’ reports of their current custodial sentence
ranged from 14 months to 22.5 years.
Circumstances of HCV acquisition
Participants’ accounts of the circumstances in which they
believed that they acquired HCV are presented as unique
cases. A theme across these accounts is the “routine” nature
of HCV seroconversion (that is, participants could not iden-
tify changes in practice that could have resulted in in-
creased HCV risk). However, alongside commentary about
the “routine” nature of the suspected HCV seoconversion
circumstances are instances in which participants made de-
cisions to inject outside of routine (particularly with differ-
ent injecting partners) because the opportunity to use
drugs arose. Whatever the circumstances of the narrated
events (routine or not), was that each participant placed
trust in their injecting partners to provide protection
against HCV (by declaring their positive status or cleaning
equipment). Indeed, awareness of and attempts to clean
equipment was a feature of each case and will be explored
in detail below.
All but one participant described sharing of injecting
equipment as the likely means of HCV transmission. One
participant (#22, female, 23 years, daily injecting, tattoo,
piercing), who reported injecting and other risks for HCV
exposure, indicated that she did not know how she ac-
quired HCV and similar to most of the remaining partici-
pants could find no change in routine that would explain
exposure to HCV, including related to injecting drug use.
Participant #11 believed that he acquired HCV when
he shared a needle/syringe with his cell mate who had
previously disclosed his positive HCV status. This situ-
ation was different from typical injecting events in that
the participant noted that he would usually inject with
his cell mate and two other inmates. The participant and
his cell mate injected together on this occasion as there
were insufficient drugs to share with two other people.
This participant held a strong belief that he would not
acquire HCV.
I took the chance, yeah … I, I just thought I was, I
don’t know, I had a gene in me body that’d beat it,
you know. I never thought I’d catch it. Doesn’t matter
how many, if I belted up bloody five units of blood, I
wouldn’t catch it. And now I got it. But I never, I
never thought I’d get it. (#11, male, 27 years, injecting
more than once per day).Participant #13 reported only injecting drugs within
prison (not in the community) and that he had shared
injecting equipment with the same person throughout
the period of incarceration leading up to the incident in-
fection. This participant could not describe how he was
likely to have acquired hepatitis C at this time: “No, it
was virtually the same as I do it any other time” (#13,
male, 22 years, injecting daily).
Participant #18 indicated that he had acquired HCV
“through shootin’ up. There’s not much else to say” and
indicated that he assumed his regular and trusted inject-
ing partner did not have hepatitis C. However, this par-
ticipant also indicated that he may have used drugs with
other people revealing the pragmatic decisions made to
share equipment outside of regular networks to facilitate
access to drugs.
I don’t think I’d used with anyone else. … But maybe I
had. Maybe there was one or two times that I used
with someone else. … [Interviewer: Why would you
use with others?] Well probably ‘cause we didn’t have
[drugs] and the only way for me to get was to use
with them. (#18, male 27 years, injecting more than
once per day, haircut where skin was cut)’.
Participant #21 described two possible scenarios in
which HCV transmission could have occurred. One in-
volved routine cleaning of equipment and the other a
gift of a pre-mixed syringe after this participant had lent
his syringe to another inmate. This account again raises
the need to trust others in the situation of limited access
to both equipment and drugs:
I knew the bloke who let me use the fit. I sort of, I
cleaned it but you still, you still can’t know. The
second time I lent my fit [needle/syringe] to a mate.
He went and used it, brought it, brought it back and
brought me back a shot. … it was already mixed up.
And I said, “Did you clean it?” and he said, “Yeah”.
And I was, I trusted the bloke. (#21, male 31 years,
injecting monthly or more often, tattoo, fight where
blood was present).
Participant #23 indicated that she preferred to smoke
cannabis in gaol rather than inject drugs. She did, how-
ever, accept the offer of an injection because she could
not access cannabis at that time and the two inmates in-
volved in this instance declared that they were HCV
negative. As an irregular injector, this participant also
did not have her own equipment to use but relied on
others to access this.
I prefer to smoke cones [of cannabis]. It’s just like that
time when I did [inject] it was like no cones going
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prefer to buy a deal of pot than inject … [I got HCV
through] sharing equipment. Sharing a needle.
[Interviewer: So what, what happened? Like why did
you share the needle?]’ Cause they swore that they
didn’t have hepatitis C and I wanted to have a shot of
Bupe [buprenorphine]. But I could have smoked it
too. … So I had options. They just, it’s better the
other way. … If I had that opportunity to be told [that
people I would be injecting drugs with had HCV], I
would have smoked it. I wouldn’t put the needle in
my arm. (#23, female, 24 years, no injecting or other
HCV risk behaviours reported).
Cleaning of injecting equipment
Without access to sterile injecting equipment in prison,
health promotion materials provide advice about clean-
ing equipment with water and a quaternary disinfectant
provided in the NSW prisons, and accessible for general
cleaning purposes. Common across all participants’ ac-
counts was knowledge that cleaning of equipment was
recommended to reduce the risk of HCV transmission
and all but one participant attempted to put these proto-
cols into practice. Among those who attempted cleaning,
external factors were described as influencing the suc-
cess of these attempts. Being able to access disinfectant
and having the time to clean equipment without coming
to the attention of correctional staff were significant bar-
riers to following recommended cleaning protocols.
Just being able to have the, the time and the, just kind
of like cleaning stuff around. … Well cleaning the, the
syringe out properly and having enough time to do it
without an officer or, you know, someone else trying
to come, come in. (#21, male, 31 years, injecting
monthly or more often, tattoo, fight where blood
was present).
Despite this level of awareness and practice of cleaning,
some participants revealed ambivalence about the advice
and practice. Among this sample, there was resignation
about the effectiveness of cleaning that was reinforced by
participants’ subsequent HCV seroconversion: that clean-
ing equipment cannot guarantee safety or prevent HCV.
Clean it with water then [disinfectant], then water
again. .. Well it’s not really safe. It’s just cleaning it
(#22, female, 23 years, injecting daily, tattoo, piercing).
Well I’ve shared needles. [Disinfected] it. What it says
to do, you know. Like three water, three
[disinfectants], three water, and I still caught hep C,
you know. (#23, female, 24 years, no injecting or other
HCV risk behaviours reported).Participant #11 had a unique attitude to cleaning in
that he equated cleaning with “weakness”. Although this
attitude was unique, it was also influenced by the need
to rush to avoid detection and lack of access to bleach
products (as opposed to the disinfectant provided).
Usin’ a needle and, you know, it’s not clean or you got
no bleach no more. What we got runnin’ water and
half the time … there was a, always a saying when I
first come here, “water’s for weak cunts”. … Who
needs cleaning? Just get, let’s get it over and done
with, you know, ‘cause we’ve got two minutes before
the screws [corrections officers] walk through the
gate, you know. Let’s get this done quick. … And I’ve
got [hepatitis C] because of that stupid, bloody little
ruling I made up, (#11, male, 27 years, injecting more
than once per day).
Sharing injecting equipment
In situations of acute limitations on access to sterile
equipment, inmates who inject must make decisions
about who they will share equipment with. Participants’
accounts were heavily invested with notions and judge-
ments of trust.
Participants relied on existing trusted relationships
(some from prior to imprisonment) to make decisions
about with whom to share injecting equipment. Assess-
ments of trustworthiness were based on perceptions of
hygiene and cleanliness (for example, how frequently in-
mates showered), the ways in which inmates carried
themselves in the prison (that is, avoiding those who
drew too much attention because of their behaviour)
and those who looked drug affected (which may also
draw unwanted attention from correctional staff ).
not dickheads … Just carry on like fuckwits, like just
being dumb cunts. Putting themselves out there. …
And like I don’t mean to be like rude or anything but
I normally go by looks. If you’re decent looking then,
yeah …But, if you look like a junkie, I’m not gonna let
you do a thing (#22, female, 23 years, injecting daily,
tattoo, piercing).
In relation to HCV, participants relied on other inmates
to disclose their HCV status and used this knowledge to
form injecting networks and make decisions about man-
aging HCV risk. By acquiring HCV, participants had be-
come aware either of the mistaken trust they had in their
own assumptions or the declarations of others.
I was shootin’ up with a bloke who I assumed didn’t
have it. For no other reason than I was an idiot …
‘Cause I trusted him. … ‘Cause I’d known him a long
time before I started shootin’. (#18, male 27 years,
Treloar et al. Harm Reduction Journal  (2015) 12:10 Page 5 of 7injecting more than once per day, haircut where blood
was present).
a lot of people specifically lie to your face just to have
a shot. You know what I mean? [Interviewer: About
what, what do they lie to you about?] That they don’t
have anything. … The two people I shared with swore
to me on their kids that they didn’t have hep C. Well
why the fuck do I have it? So that’s the way I look at
it, you know. And that’s how low they will stoop, to
swear on their own kids, to say that they don’t have
[hepatitis C]. Because, if they told me, I was happy
just to smoke it. (#23, female, 24 years, no injecting or
other HCV risk behaviours reported).
Responses to HCV diagnosis
The diagnosis of HCV was an emotionally charged ex-
perience for some participants with reports of anger and
blame (at others who transmitted HCV infection) and
regret (particularly in relation to cleaning of equipment).
These reactions were also fed by concerns about HCV
interfering with pre- and post-release plans, the associ-
ation of HCV status with a “junkie” identity and the fear
that participants could also have acquired HIV (perceived
as a more serious and life-threatening infection than
HCV) were also evident.
And then it shattered me. … It’s a blood virus that I
don’t want, you know. Junk-bags got it and I’ve got it.
… And now I joined ‘em. You know what I mean?
I’m, I’ve got hepatitis. That’s the way I look at it: I’m a
junkie. … I shouldn’t have had it. I shouldn’t have
done what I was doin’, you know. I kick meself every
day. (#11, male, 27 years, injecting more than once
per day).
Participants’ reactions to diagnosis also generated
varying responses to those who were perceived to be in-
volved in HCV transmission and varying impacts on
subsequent injecting practice. One of the six participants
reported acting on her anger at acquiring HCV and con-
fronted the person they believed was involved in HCV
transmission. The reactions of these participants were
grounded more in feelings of self-regret in relation to
cleaning.
I don’t hate him ‘cause he gave it to me. I blame
myself more than anyone and so it’s my fault that I
got hep c - not his fault. I should have been more
stringent on the cleaning process (#18, male 27 years,
injecting more than once per day, haircut where skin
was cut).
The impact of HCV diagnosis on injecting was varied
from no change, to changes in drug use practice, and forsome, a ceasing of injecting drug use. Two participants
reported a change in practice following HCV infection.
One participant reported restricting his injecting net-
work to only one other person who had previously re-
vealed a HCV positive status. The other participant
reported a change in cleaning practices to avoid further
HCV infections.
a bit more vigilant in the cleaning process. … Before
maybe I might have lapsed, you know. But now it’s
vigilant, every, you’ve gotta make sure you have clean
every time … ‘cause I don’t wanna get more strands or
genotypes (#18, male 27 years, injecting more than
once per day, haircut where skin was cut).
Two participants reported ceasing injecting drug use
and one of these was as a result of the “wake-up call”
that the HCV diagnosis provided. The other participant
had ceased injecting before being notified of their HCV
diagnosis in an effort to “get cleaned up” (#13, male,
22 years, injecting daily) prior to release from prison.
Yeah, it was just a wake-up call, really. You know
what I mean? Like to stop … it was a couple of
months from when I used and then I flushed the
equipment, you know, the fits. … to me it was like a
wake-up call. I had to (#21, male 31 years, injecting
monthly or more often, tattoo, fight where blood
was present).
Discussion
It is unsurprising that these participants described shar-
ing of injecting equipment as leading to HCV transmis-
sion as this is a well-established risk factor for HCV
infection, compounded by lack of prison programs for
distribution of sterile equipment in most countries of
the world [15]. Indeed, the factors that participants
noted such as the importance of social networks, the dif-
ficulties in cleaning equipment, the commodification of
equipment (resulting in the gift of a pre-mixed syringe)
and the attitude of some prisoners towards their health
have been raised in previous literature [8,10,16-18].
Inmates who inject drugs typically do so within prison
at lower rates than in the community [13,19], and there
is evidence that some inmates initiate injecting in prison
[20]. Decisions to inject in prison, may be related to a
number of factors including untreated dependence on
illicit drugs, boredom and social bonding [17,21]. In the
absence of prison-based needle and syringe programs,
the harm reduction strategy available to inmates who in-
ject is cleaning equipment with disinfectant via a recom-
mended protocol of three rinses with water followed by
three rinses with disinfectant, and three further rinses
with water. These participants were all aware of these
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put these into practice. Restrictions on the time available
to clean equipment in the prison environment without
coming to the attention of the correctional staff were
noted. Such situational limitations on cleaning have been
previously shown to modify the protective effect of equip-
ment cleaning [22]. However, there was also a sense of
fatalism for some participants noting that cleaning was
“not safe” and that HCV transmission had occurred
despite following cleaning recommendations. In addition,
a recent meta-analysis suggested bleaching had no effect
on HCV transmission [23] and epidemiological analysis of
associations with incident HCV infection in the HITS-p
cohort, those who reported “always” using disinfectant
had no reduction in HCV incidence [1].
The importance of the organisation of injecting drug
use in trusted social networks is another difficult area
for prison health agencies to address [24]. Previous
writers have examined the fears held by HIV positive
inmates of being excluded from injecting opportunities,
and social networks, if they disclose their status [10].
These findings suggest that similar social influences are
at play in decisions about disclosure of HCV [25,26],
despite the much higher prevalence of this infection
than HIV. However, knowing (or assuming) others’ HCV
status was one key element of decisions about injecting
partners and negotiating HCV risk, across a range of
prisons with differing accommodation and other orga-
nisational arrangements. As prisoners are moved between
prisons, these networks will form and re-form. How
best to address the social organisation of drug use
requires further research and the input of prisoners in any
resultant responses to examine both the risk and the posi-
tive outcomes of social relationships within prison [16].
This is the first study to examine the accounts of con-
tinuously incarcerated inmates who have acquired HCV
within prison. The findings of this small study of six
prison inmates cannot be generalised to the population
of inmates at risk of HCV. However, this study was care-
fully designed to provide participants with the opportun-
ity to undertake an interview with a trusted research
nurse, who was not an employee of the corrections
authorities, and who was known to participants via their
regular participation in the HITS-p cohort. Also, data
was collected within close temporal proximity to acute
infection, largely averting issues of recall and other
biases that may occur within studies of ex-inmates. Al-
though it is well known that prison inmates can acquire
multiple HCV infections [27], this account focused on
their first confirmed HCV infection to avoid discussion
of multiple possible events of risk over periods of time.
These findings also highlight the usefulness of qualitative
data in making sense of epidemiological and behavioural
surveillance data. When responding to the behavioursurvey, participant #23 reported no injecting or other
HCV risk behaviours at the time of HCV acquisition.
However, her narrative account clearly demonstrates
that she did inject, although this was an unusual occur-
rence which could have accounted for the response she
gave to the survey question. It is also interesting to note
that while three of the six participants reported other
exposures to blood (via tattooing, piercing, violence and
haircuts), their accounts of HCV acquisition focused
exclusively on injecting drug use.
It is recognised that no single intervention is effective
for the prevention of HCV [23] and combined ap-
proaches are recommended for both prevention of HIV
[28,29] and HCV among PWID [30,31]. Participants’ ac-
counts focused on reuse of equipment and inadequate
use of disinfectant as determining factors of HCV acqui-
sition. Another strategy shown to effect HCV risk is the
provision of opiate substitution treatment (OST). In
NSW prisons, methadone and buprenorphine were pro-
vided to opioid-dependent inmates by a health service
that operates independently of corrections authorities
[32,33]. One participant was receiving OST despite four
reporting daily or more frequent injection. There is
long-standing evidence of the benefits of OST on nu-
merous health and well-being measures [34] and more
recent evidence has shown the impact of OST on reduc-
tion of reincarceration rates [35]. OST of adequate dose
and duration has the potential to impact the “pool” of
people injecting within the prison environment by
decreasing frequency of injecting among those on OST
[36,37] and should be considered as part of a package of
HCV prevention strategies.
Addressing the risk of HCV acquisition among prison
inmates is complex when distribution of sterile equip-
ment is prohibited, equipment cleaning procedures are
difficult to enact (or are ineffective) and prisoners may
not have access to OST. This study adds to the evidence
that inmates are required to make difficult choices about
risk, and risk reduction. What should also be noted is
that without access to services equivalent to community
standards (that is, access to harm reduction measures),
HCV infections continue to occur among the most
vulnerable, marginalised and excluded members of our
society compounding the ill-health and social position
of these individuals as well as generating significant
societal and health care costs related to the manage-
ment of these infections.
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